BiotechTube

Non-Small Cell Lung Cancer (NSCLC)

9 competing products in clinical development for Non-Small Cell Lung Cancer (NSCLC).

Pipeline by Phase

Phase 16
Phase 33

All Products (9)

ProductCompanyStageStatusHype
Datopotamab deruxtecan (Dato-DXd) + DocetaxelDaiichi SankyoPhase 3Recruiting
47
Eribulin + TPC -Vinorelbine,Gemcitabine,Docetaxel, and PemetrexedEisaiPhase 3Completed
40
gilteritinibAstellas PharmaPhase 1Recruiting
36
HER3-DXd + HER3-DXd + Osimertinib + Osimertinib + HER3-DXd + HER3-DXd + OsimertinibDaiichi SankyoPhase 1Active
33
HER3-DXd (FL-DP) + HER3-DXd (CTM-1 Lyo-DP) + HER3-DXd (CTM-3 Lyo-DP)Daiichi SankyoPhase 1Active
33
naquotinib mesilate + Erlotinib + GefitinibAstellas PharmaPhase 3Terminated
32
naquotinib + midazolamAstellas PharmaPhase 1Completed
29
DS-1205c + OsimertinibDaiichi SankyoPhase 1Terminated
21
naquotinibAstellas PharmaPhase 1Terminated
21